A425 EGFR Based on Cystatin-C, Creatinine, and Age Is Independently Associated with Survival in Myeloma

Meletios A Dimopoulos; Efstathios Kastritis; Eirini Katodritou; Evangelos Tsiftsakis; D. Christoulas; Evgenia Verrou; Eurydiki Michalis; Anastasia Pouli; Kostas Zervas; Evangelos Terpos

doi:10.1016/s1557-9190(11)70578-9

Related publications

Article2025

Discordance in Creatinine- and Cystatin C–Based eGFR and Clinical Outcomes

Michelle M. Estrella, Shoshana H. Ballew, Yingying Sang, Morgan E. Grams, Josef Coresh, Aditya Surapaneni, Natalia Alencar de Pinho, Johan Ärnlöv, Hermann Brenner, Juan Jesús Carrero, Teresa K. Chen, Debbie L. Cohen, Mary Cushman, Ron T. Gansevoort, Shih‐Jen Hwang, Lesley A. Inker, Joachim H. Ix, Keiko Kabasawa, Tsuneo Konta, Jennifer S. Lees, Kevan R. Polkinghorne, Michael G. Shlipak, Robin W.M. Vernooij, David C. Wheeler, Ashok K. Yadav, Andrew S. Levey, Kai‐Uwe Eckardt, Teresa K. Chen, Yingying Sang, Morgan E. Grams, Josef Coresh, Steven J. Chadban, Kevan Polkinghorne, Nisha Bansal, Joachim H. Ix, Michael G. Shlipak, Marie-Hélène Metzger, Bénédicte Stengel, Martin Landray, John Townend, Jonathan Emberson, Chi‐yuan Hsu, Wei Yang, Amanda Anderson, Hermann Brenner, Dietrich Rothenbacher, Ben Schöttker, Hannah Stocker, Daniel Levy, Martin Larson, Anna Köttgen, Peggy Sekula, Ulla T. Schultheiß, Markus P. Schneider, Vivek Kumar, Manisha Sahay, Narayan Prasad, Robin W.M. Vernooij, Andrew S. Levey, Lesley A. Inker, Mark J. Sarnak, Orlando M. Gutiérrez, Mary Cushman, Stephan J. L. Bakker, Lyanne M. Kieneker, Marco van Londen, Katharine L. Cheung, Titilayo O. Ilori, Edouard L. Fu, Anne‐Laure Faucon, Aurora Caldinelli, Antoine Créon, Tsuneo Konta, Kazunobu Ichikawa, Satoru Nagase, Masafumi Watanabe, Jennifer S. Lees, Patrick B. Mark, Anders Larsson, Vilmantas Giedraitis, Keiko Kabasawa, Yumi Ito, Junta Tanaka, Ichiei Narita, Michelle M. Estrella, Shoshana H. Ballew, Juan Jesús Carrero, Ron T. Gansevoort, Kunihiro Matsushita, Dorothea Nitsch, Angela Yee‐Moon Wang, Carina Flaherty, Aditya Surapaneni

Article2009

Cystatin-C is an independent prognostic factor for survival in multiple myeloma and is reduced by bortezomib administration

Evangelos Terpos, Eirini Katodritou, E. Tsiftsakis, Efstathios Kastritis, D. Christoulas, Anastasia Pouli, Eurydiki Michalis, Eugenia Verrou, Konstantinos Anargyrou, Konstantinos Tsionos, Meletios A Dimopoulos, Konstantinos Zervas

Letter2012

Validity of cystatin C/creatinine ratio in pediatric kidney disease

Se Jin Park, Jae Il Shin

Article2007

Cystatin-C Is a Sensitive Marker of Renal Impairment with an Independent Predictive Value for Survival in Multiple Myeloma; Reduction Post Bortezomib Monotherapy.

Evangelos Terpos, Eirini Katodritou, Evangelos Tsiftsakis, Efstathios Kastritis, Anastasia Pouli, Dimitrios Christoulas, Evridiki Michali, Evgenia Verrou, Anastasia Banti, Konstantinos Tsionos, Meletios A Dimopoulos, Konstantinos Zervas

Article2015

Neutrophil Gelatinase–Associated Lipocalin and Cystatin C Are Sensitive Markers of Renal Injury in Patients With Multiple Myeloma

Gerasimos-Petros Papassotiriou, Efstathios Kastritis, Μαρία Γκοτζαμανίδου, Dimitrios Christoulas, Evangelos Eleutherakis‐Papaiakovou, Magdalini Migkou, Maria Gavriatopoulou, Μαρία Ρούσσου, Alexandra Margeli, Ioannis Papassotiriou, Meletios A Dimopoulos, Evangelos Terpos